Member Info for comek2

Forgot to add nyct is now in the radar for other pharmaceutical companies for collaborative work, if not takeover.

Considering nyct are the first one if not the only to have such a test, this will be a great FREE marketing for other nyct products. From now on, more countries health services providers will take nyct very seriously. So the future is more rosy me thinks.

Those who are saying the test cost £4 person meaning ncyt will sell it at that price are fools. The £4 is what it cost the providers to administer it, ie it’s CHEAP. Not that ncyt will sell the test technology at £4, lol. The technology cost per provider will be in the 1million+. How much money went into R&D to provide such a test for god sake? A Chinese fireworks kit cost £4, lol......talking of fireworks, wait for news of sales and FDA approval which will be coming anytime this weekend.....it’s a worldwide emergency.

Thanks for the links DRichi.
And yet the self styled PPC guru Brasso3 thinks it’s a bad move. It’s certainly is for him since he is trading (he’s been sussed out at ad*fn site) and he must be sitting on a massive loss, hence his constant moaning even with such excellent news. Exchanging guaranteed payback of loan + interest with taking risk with shares is no brainier that it’s a vote of confidence in PPC, no to mention the no debt factor. Such big hitter institution with £177 billion yearly turnover wouldn’t bother with such small company if they didn’t see it in their interests...and are privy to information before they commit we PIs aren’t.

ecclescake, are you a welder, lol?

Sorry Chewlse, what news you’re talking about, or have I missed something? Cheers